pubmed-article:19747051 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:19747051 | lifeskim:mentions | umls-concept:C0035820 | lld:lifeskim |
pubmed-article:19747051 | lifeskim:mentions | umls-concept:C0035647 | lld:lifeskim |
pubmed-article:19747051 | lifeskim:mentions | umls-concept:C0162340 | lld:lifeskim |
pubmed-article:19747051 | lifeskim:mentions | umls-concept:C1335713 | lld:lifeskim |
pubmed-article:19747051 | lifeskim:mentions | umls-concept:C2717970 | lld:lifeskim |
pubmed-article:19747051 | lifeskim:mentions | umls-concept:C0243077 | lld:lifeskim |
pubmed-article:19747051 | pubmed:issue | 5 | lld:pubmed |
pubmed-article:19747051 | pubmed:dateCreated | 2010-5-3 | lld:pubmed |
pubmed-article:19747051 | pubmed:abstractText | The first aim of this study was to diagnose more aggressive and potentially recurrent meningiomas using an in vitro embryonic chick heart invasiveness assay in which lysosomal enzyme cathepsin B was used as the invasiveness marker. The second aim was to confirm if cathepsin B and/or cathepsin L and their endogenous inhibitors were also prognostic parameters in the clinical study of 119 patients with meningioma. | lld:pubmed |
pubmed-article:19747051 | pubmed:language | eng | lld:pubmed |
pubmed-article:19747051 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19747051 | pubmed:citationSubset | AIM | lld:pubmed |
pubmed-article:19747051 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19747051 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19747051 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19747051 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19747051 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19747051 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19747051 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:19747051 | pubmed:month | May | lld:pubmed |
pubmed-article:19747051 | pubmed:issn | 1933-0693 | lld:pubmed |
pubmed-article:19747051 | pubmed:author | pubmed-author:MartinPierre-... | lld:pubmed |
pubmed-article:19747051 | pubmed:author | pubmed-author:DussertChrist... | lld:pubmed |
pubmed-article:19747051 | pubmed:author | pubmed-author:BlejecAndrejA | lld:pubmed |
pubmed-article:19747051 | pubmed:author | pubmed-author:LahTamara TTT | lld:pubmed |
pubmed-article:19747051 | pubmed:author | pubmed-author:De RidderLeoL | lld:pubmed |
pubmed-article:19747051 | pubmed:author | pubmed-author:TrinkausMihaM | lld:pubmed |
pubmed-article:19747051 | pubmed:author | pubmed-author:MetellusPhili... | lld:pubmed |
pubmed-article:19747051 | pubmed:author | pubmed-author:NanniIsabelle... | lld:pubmed |
pubmed-article:19747051 | pubmed:author | pubmed-author:Rajcevi?UrosU | lld:pubmed |
pubmed-article:19747051 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:19747051 | pubmed:volume | 112 | lld:pubmed |
pubmed-article:19747051 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:19747051 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:19747051 | pubmed:pagination | 940-50 | lld:pubmed |
pubmed-article:19747051 | pubmed:meshHeading | pubmed-meshheading:19747051... | lld:pubmed |
pubmed-article:19747051 | pubmed:meshHeading | pubmed-meshheading:19747051... | lld:pubmed |
pubmed-article:19747051 | pubmed:meshHeading | pubmed-meshheading:19747051... | lld:pubmed |
pubmed-article:19747051 | pubmed:meshHeading | pubmed-meshheading:19747051... | lld:pubmed |
pubmed-article:19747051 | pubmed:meshHeading | pubmed-meshheading:19747051... | lld:pubmed |
pubmed-article:19747051 | pubmed:meshHeading | pubmed-meshheading:19747051... | lld:pubmed |
pubmed-article:19747051 | pubmed:meshHeading | pubmed-meshheading:19747051... | lld:pubmed |
pubmed-article:19747051 | pubmed:meshHeading | pubmed-meshheading:19747051... | lld:pubmed |
pubmed-article:19747051 | pubmed:meshHeading | pubmed-meshheading:19747051... | lld:pubmed |
pubmed-article:19747051 | pubmed:meshHeading | pubmed-meshheading:19747051... | lld:pubmed |
pubmed-article:19747051 | pubmed:meshHeading | pubmed-meshheading:19747051... | lld:pubmed |
pubmed-article:19747051 | pubmed:meshHeading | pubmed-meshheading:19747051... | lld:pubmed |
pubmed-article:19747051 | pubmed:meshHeading | pubmed-meshheading:19747051... | lld:pubmed |
pubmed-article:19747051 | pubmed:meshHeading | pubmed-meshheading:19747051... | lld:pubmed |
pubmed-article:19747051 | pubmed:meshHeading | pubmed-meshheading:19747051... | lld:pubmed |
pubmed-article:19747051 | pubmed:meshHeading | pubmed-meshheading:19747051... | lld:pubmed |
pubmed-article:19747051 | pubmed:meshHeading | pubmed-meshheading:19747051... | lld:pubmed |
pubmed-article:19747051 | pubmed:meshHeading | pubmed-meshheading:19747051... | lld:pubmed |
pubmed-article:19747051 | pubmed:meshHeading | pubmed-meshheading:19747051... | lld:pubmed |
pubmed-article:19747051 | pubmed:meshHeading | pubmed-meshheading:19747051... | lld:pubmed |
pubmed-article:19747051 | pubmed:year | 2010 | lld:pubmed |
pubmed-article:19747051 | pubmed:articleTitle | Toward understanding recurrent meningioma: the potential role of lysosomal cysteine proteases and their inhibitors. | lld:pubmed |
pubmed-article:19747051 | pubmed:affiliation | Department of Genetic Toxicology and Cancer Biology, National Institute of Biology, Ljubljana, Slovenia. tamara.lah@nib.si | lld:pubmed |
pubmed-article:19747051 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:19747051 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |